Sectors
GTBP
GT Biopharma, Inc.
0.29
1 x 0.30
1 x 0.30
bid
ask
-
0.01
4.67%
1 @ 06:07 PM
0.30 +0.01 (4.34%)
| Ytd | -63.57% | |
| 1y | -69.41% |
0.29
day range
0.32
0.26
52 week range
1.37
| Open | 0.31 | Prev Close | 0.30 | Low | 0.29 | High | 0.32 | Mkt Cap | 12.90M |
| Vol | 313.50K | Avg Vol | 917.09K | EPS | 5.21 | P/E | 0.05 | Forward P/E | -0.26 |
| Beta | 0.57 | Short Ratio | 0.71 | Inst. Own | 67.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 0.36 | 200-d Avg | 0.49 | 1yr Est | 11.00 |
| Income Statement | |||
| Operating Expenses | 4.51M | ||
| Research and Development Expense | 1.06M | ||
| Selling, General and Administrative Expense | 3.46M | ||
| Operating Income | -4.51M | ||
| Interest Expense | 64.00K | ||
| Net Income | -4.52M | ||
| Net Income Common Stock | -4.59M | ||
| Net Income Common Stock (USD) | -4.59M | ||
| Consolidated Income | -4.52M | ||
| Earnings per Basic Share | -0.12 | ||
| Earnings per Basic Share (USD) | -0.12 | ||
| Earnings per Diluted Share | -0.12 | ||
| Earning Before Interest & Taxes (EBIT) | -4.45M | ||
| Earning Before Interest & Taxes (USD) | -4.45M | ||
| Preferred Dividends Income Statement Impact | 74.00K | ||
| Weighted Average Shares | 38.82M | ||
| Weighted Average Shares Diluted | 38.82M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.05M | ||
| Cash and Equivalents (USD) | 5.05M | ||
| Current Assets | 5.79M | ||
| Total Assets | 5.79M | ||
| Current Liabilities | 2.22M | ||
| Total Liabilities | 2.22M | ||
| Accumulated Retained Earnings (Deficit) | -731.43M | ||
| Shareholders Equity | 3.57M | ||
| Shareholders Equity (USD) | 3.57M | ||
| Trade and Non-Trade Payables | 1.02M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 297.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.96M | ||
| Net Cash Flow from Operations | -4.26M | ||
| Share Based Compensation | 46.00K | ||